Pacific Biosciences of California Inc

23 wrz 2026, 20:07 UTC

Pacific Biosciences is sharply lower, following a broader market decline and significant losses in key holdings of the ARK Genomic Revolution ETF.

22 wrz 2026, 23:06 UTC

Pacific Biosciences of California Inc is trading lower in after-market hours, having declined from earlier gains and remaining above its 20-day moving average.

21 wrz 2026, 22:35 UTC

In after-market trading, Pacific Biosciences of California Inc is roughly flat since Monday's close, reflecting routine performance near the lower end of its one-month range.

18 wrz 2026, 23:51 UTC

Pacific Biosciences of California Inc declined during after-market trading, moving lower since Friday's close and currently below its 20-day moving average.

17 wrz 2026, 20:02 UTC

Pacific Biosciences is sharply higher, reflecting a positive trend in the life sciences sector, alongside gains in the ARK Genomic Revolution ETF.

16 wrz 2026, 23:16 UTC

Pacific Biosciences of California Inc is trading roughly flat in after-market hours, remaining below its 20-day moving average after four consecutive higher sessions.

15 wrz 2026, 23:11 UTC

Pacific Biosciences of California is gaining in after-market trading, supported by a positive performance backdrop and four consecutive higher closes.

14 wrz 2026, 20:05 UTC

Pacific Biosciences of California is higher today, influenced by social media discussions on Tempus AI's $80 price target and broader market sentiment.

11 wrz 2026, 19:02 UTC

Pacific Biosciences of California is trading higher, continuing its recovery after three sessions of declines. No specific news was identified for the upward movement.

9 wrz 2026, 20:01 UTC

Pacific Biosciences of California shares are lower after UBS initiated coverage with a Neutral rating and a price target of $1.35.

8 wrz 2026, 23:56 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, despite fluctuations, and remain above their 20-day moving average.

3 wrz 2026, 19:56 UTC

Pacific Biosciences of California is lower today with no specific news. The broader market sees falling Treasury yields amid jobless claims data.

2 wrz 2026, 23:46 UTC

Pacific Biosciences of California is higher in after-market trading, despite no specific news, amid a weaker ADP payrolls report that may ease rate hike concerns.

1 wrz 2026, 23:46 UTC

Pacific Biosciences of California remained roughly flat during after-market hours. This follows five consecutive sessions of lower finishes.

31 sie 2026, 20:07 UTC

Pacific Biosciences is trading lower, reflecting broader market declines amid heightened interest rate hike expectations from the Jackson Hole Economic Symposium.

28 sie 2026, 23:36 UTC

Pacific Biosciences is trading higher in after-market hours, reaching a level significantly above Friday's close amid broader market pressures from rising Treasury yields.

27 sie 2026, 20:07 UTC

Pacific Biosciences of California is lower today, with no specific news driving the decline. The broader market has also been down since Wednesday.

26 sie 2026, 23:06 UTC

Pacific Biosciences of California traded roughly flat in after-market hours, with no specific news driving the activity. The stock remains near its one-month range's upper end.

25 sie 2026, 23:01 UTC

Pacific Biosciences is lower in after-market trading, with no specific news identified. The broader market has also retreated amid falling crude oil prices.

24 sie 2026, 23:01 UTC

Pacific Biosciences of California is trading higher in after-hours, recovering from an initial low and remaining above its 20-day moving average.

21 sie 2026, 22:51 UTC

Shares of Pacific Biosciences of California declined in after-market trading, continuing a downward trend amid broader market weakness and rising Treasury yields.

20 sie 2026, 19:51 UTC

Pacific Biosciences is lower today, reflecting broader market declines and trading near the lower end of its one-month range.

19 sie 2026, 23:11 UTC

Pacific Biosciences of California shows a modest increase in after-market trading, reflecting stability amid a broader positive trend in correlated assets.

18 sie 2026, 23:16 UTC

Pacific Biosciences shares declined in after-hours trading, continuing a downward trend since Tuesday's close, amid broader market sentiment reflected by the Russell 2000 Index.

17 sie 2026, 19:11 UTC

Pacific Biosciences reported second-quarter revenue of $39 million, with shares trading higher today after initially dropping. The company is undergoing a leadership transition.

14 sie 2026, 19:36 UTC

Pacific Biosciences reported second-quarter revenue of $39.01 million, missing estimates. Shares are trading lower amid concerns over funding constraints and adoption challenges.

13 sie 2026, 23:06 UTC

Pacific Biosciences of California Inc. gained modestly in after-market trading, reflecting broader market trends seen in correlated assets.

12 sie 2026, 23:41 UTC

Pacific Biosciences shares are lower in after-market hours, trading below their 20-day moving average amid easing inflation concerns and broader market conditions.

11 sie 2026, 20:06 UTC

Pacific Biosciences of California is trading higher in a routine session. The stock remains below its 20-day moving average despite today's gains.

10 sie 2026, 23:21 UTC

Pacific Biosciences of California Inc. shares are higher in after-market trading, recovering from earlier losses and gaining since Monday's close.